Global Intranasal Drug Delivery Market
Global Intranasal Drug Delivery Market 2014-2018
Intranasal drug delivery is used to treat local diseases in the nose and paranasal sinus such as allergic and non-allergic rhinitis and sinusitis. The nose is considered an ideal administrative route for needle-free vaccination and systematic drug delivery. Continuous advances in technology in intranasal drug delivery products help achieve efficient treatment. Intranasal drug delivery systems provide an easy mode of administration for patients on long-term therapy, avoid risk of overdose, and enhance the bioavailability of the drug.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Intranasal Drug Delivery market for the period 2014-2018. To calculate the market size, the report considers revenue generated from different Intranasal Drug Delivery products like nasal gels, nasal drops, nasal powder, nasal sprays and nasal vaccines.
Key Regions
EMEA
APAC
Americas
Key Vendors
Becton, Dickinson and Company
GlaxoSmithKline plc
Johnson & Johnson
Novartis AG
Other Prominent Vendors
Actiza Pharmaceutical
Aptar Group
Korten Pharmaceuticals
OptiNose
Patheon
Vee Remedies
Zymeth Wellness
Key Market Driver
Increase in Aging Population
For a full, detailed list, view our report.
Key Market Challenge
Risk of Overdosing and Side-effects
For a full, detailed list, view our report.
Key Market Trend
Increased Adoption of Non-invasive Products
For a full, detailed list, view our report.
Key Questions Answered in this Report
What will the market size be in 2018 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
For more insights, view our Global Intranasal
Intranasal drug delivery is used to treat local diseases in the nose and paranasal sinus such as allergic and non-allergic rhinitis and sinusitis. The nose is considered an ideal administrative route for needle-free vaccination and systematic drug delivery. Continuous advances in technology in intranasal drug delivery products help achieve efficient treatment. Intranasal drug delivery systems provide an easy mode of administration for patients on long-term therapy, avoid risk of overdose, and enhance the bioavailability of the drug.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Intranasal Drug Delivery market for the period 2014-2018. To calculate the market size, the report considers revenue generated from different Intranasal Drug Delivery products like nasal gels, nasal drops, nasal powder, nasal sprays and nasal vaccines.
Key Regions
EMEA
APAC
Americas
Key Vendors
Becton, Dickinson and Company
GlaxoSmithKline plc
Johnson & Johnson
Novartis AG
Other Prominent Vendors
Actiza Pharmaceutical
Aptar Group
Korten Pharmaceuticals
OptiNose
Patheon
Vee Remedies
Zymeth Wellness
Key Market Driver
Increase in Aging Population
For a full, detailed list, view our report.
Key Market Challenge
Risk of Overdosing and Side-effects
For a full, detailed list, view our report.
Key Market Trend
Increased Adoption of Non-invasive Products
For a full, detailed list, view our report.
Key Questions Answered in this Report
What will the market size be in 2018 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
For more insights, view our Global Intranasal